Registry Study for Proton Therapy Outcomes
This study is currently recruiting participants.
Verified December 2012 by Proton Collaborative Group
Sponsor:
Proton Collaborative Group
Information provided by (Responsible Party):
Proton Collaborative Group
ClinicalTrials.gov Identifier:
NCT01255748
First received: December 6, 2010
Last updated: December 17, 2012
Last verified: December 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this research study is to collect and analyze information from patients being treated with proton therapy.
| Condition | Intervention |
|---|---|
|
Solid Tumors |
Radiation: Proton Therapy |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Evaluation Tracking Project: A Prospective Chart Review of Patients Treated With Proton Therapy |
Resource links provided by NLM:
Further study details as provided by Proton Collaborative Group:
Primary Outcome Measures:
- Define outcomes for patients treated at participating institutions [ Time Frame: Up to 10 years ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Determine strategies necessary to improve patients outcome and decrease toxicities related to treatments and procedures [ Time Frame: Annually PRN ] [ Designated as safety issue: Yes ]
- Improve patient care by an adequate understanding of the results and patient population at participating institutions [ Time Frame: Reviewed Annually PRN ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 5000 |
| Study Start Date: | June 2009 |
| Groups/Cohorts | Assigned Interventions |
|---|---|
| Treatment with Proton Therapy |
Radiation: Proton Therapy
Outcomes Tracking
|
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
Primary care clinic
Criteria
Inclusion Criteria:
- Planned treatment with proton radiation
- Ability to understand and sign IRB approved consent
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01255748
Contacts
| Contact: Kimberly Hahn, RN, CCRP | 812-330-6653 | kim.hahn@pcgresearch.org |
| Contact: Angela Piper, MBA | 765-327-0344 | angela.piper@pcgresearch.org |
Locations
| United States, Illinois | |
| ProCure Proton Therapy Center | Recruiting |
| Warrenville, Illinois, United States, 60555 | |
| Contact: Lori Abruscato, BS 630-821-6397 lori.abruscato@chi.procure.com | |
| Principal Investigator: William Hartsell, MD | |
| United States, New Jersey | |
| ProCure Proton Therapy Center | Recruiting |
| Somerset, New Jersey, United States, 08873 | |
| Contact: Nina Sullivan, RN 732-357-2626 nina.sullivan@nj.procure.com | |
| Principal Investigator: Brian Chon, MD | |
| United States, Oklahoma | |
| ProCure Treatment Centers, Inc. | Recruiting |
| Oklahoma City, Oklahoma, United States, 73142 | |
| Contact: Sameer Keole, MD 405-773-6722 Sameer.Keole@okc.procure.com | |
| Contact: Tisha Adams, MS, CCRC 405-773-6775 tisha.adams@okc.procure.com | |
| Principal Investigator: Sameer Keole, MD | |
Sponsors and Collaborators
Proton Collaborative Group
Investigators
| Study Chair: | Carlos Vargas, MD | Proton Collaborative Group |
More Information
No publications provided
| Responsible Party: | Proton Collaborative Group |
| ClinicalTrials.gov Identifier: | NCT01255748 History of Changes |
| Other Study ID Numbers: | REG001-09 |
| Study First Received: | December 6, 2010 |
| Last Updated: | December 17, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Proton Collaborative Group:
|
cancer, proton, radiation |
ClinicalTrials.gov processed this record on May 19, 2013